Most Read Articles
Roshini Claire Anthony, 29 May 2020

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

5 days ago
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.
Dr. Wong Soon Tee, 28 May 2020
Acne is a common skin problem seen in primary care. Dr Wong Soon Tee of Assurance Skin Clinic at Mt Elizabeth Novena Hospital, Singapore shares his insights with Pearl Toh on how to manage acne in the primary care setting.
27 May 2020
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.

HBeAg status implicated in liver pathology in chronic hepatitis B

20 Jan 2020

Patients with chronic hepatitis B (CHB) virus infection who are HBeAg-negative are more likely to have advanced liver fibrosis than those with a positive HBeAg status, a study has found.

Researchers reviewed the medical records of 683 treatment-naïve CHB patients who had undergone liver biopsy. They applied the propensity score-matching (PSM) method to adjust the imbalance of baseline confounders between HBeAg-positive (n=345) and HBeAg-negative (n=338) CHB patients, with 123 patients included in each group.

Compared with HBeAg-positive CHB patients, those who were HBeAg-negative showed significantly advanced liver fibrosis (p=0.03). Moreover, the latter had more severe liver inflammation (p=0.037). 

In multivariate regression models, significant liver fibrosis was associated with platelets (PLT; odds ratio [OR], 0.994, 95 percent confidence interval [CI], 0.991–0.997; p<0.001), gamma-glutamyl transpeptidase (GGT; OR, 1.007, 95 percent CI, 1.003–1.011; p<0.001) and HBeAg-negative status (OR, 1.887, 95 percent CI, 1.157–3.077; p=0.011).

Meanwhile, predictors of significant liver inflammation were PLT (OR, 0.993, 95 percent CI, 0.990–0.996; p<0.001), GGT (OR, 1.006, 95 percent CI, 1.001–1.011; p<0.017) and HBV DNA (OR, 1.138, 95 percent CI, 1.030–1.257; p=0.011).

While the exact mechanism underlying the association between HBeAg-negative hepatitis and advanced liver fibrosis is unknown, it may involve the core promoter mutation found in HBeAg-negative CHB patients. Its presence may increase hepatitis B virus replication ability, resulting in enhanced viral level in the hepatocyte, therefore causing liver damage by the host immune, the researchers explained. Furthermore, liver fibrogenesis may not be solely caused by hepatitis activity but also other influencing factors. [Cell Immunol 2012;276:35-41; Liver Int 2007;27:1356-1363]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 29 May 2020

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

5 days ago
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.
Dr. Wong Soon Tee, 28 May 2020
Acne is a common skin problem seen in primary care. Dr Wong Soon Tee of Assurance Skin Clinic at Mt Elizabeth Novena Hospital, Singapore shares his insights with Pearl Toh on how to manage acne in the primary care setting.
27 May 2020
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.